Polish tennis star Iga Świątek has accepted a one-month suspension after testing positive for a banned substance, the International Tennis Integrity Agency (ITIA) announced.
Świątek, a five-time grand slam winner, tested positive for the prohibited substance trimetazidine.
The ITIA said they found Świątek’s “level of fault was considered to be at the lowest end of the range for ‘No Significant Fault or Negligence.’”
“The ITIA accepted that the positive test was caused by the contamination of a regulated non-prescription medication (melatonin), manufactured and sold in Poland that the player had been taking for jet lag and sleep issues, and that the violation was therefore not intentional,” the ITIA said in Thursday’s statement.
The ITIA offered Świątek a suspension on November 27, which she accepted. “The player was provisionally suspended from 22 September until 4 October, missing three tournaments, which counts towards the sanction, leaving eight days remaining.
“In addition, the player also forfeits prize money from the Cincinnati Open, the tournament directly following the test,” the ITIA added.
A spokesperson for the World Anti-Doping Agency (WADA) said in a statement to CNN: “As it does with all cases, WADA will carefully review this decision by the ITIA and reserves the right to take an appeal to the Court of Arbitration for Sport, as appropriate.”
The No. 2 ranked women’s tennis player said she was shocked by the positive test.
“It was a blow for me, I was shocked and this whole situation made me very anxious. At first, I couldn’t understand how that was even possible and where it came from,” Świątek said in a video posted to social media Thursday.
The 23-year-old said she instantly cooperated with the ITIA and started running tests on nutritional supplements and medications. These tests found that melatonin was contaminated which Świątek said she takes to help sleep.
